Clinico-epidemiological profile and adherence to antitubercular treatment of tuberculosis patients in a city of Maharashtra
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20203937Keywords:
Clinico-epidemiological profile, Morisky medication adherence scale-4, TuberculosisAbstract
Background: Poor patient adherence to the treatment regimen is a major cause of treatment failure and of the emergence of drug-resistant TB. Present study was conducted to study clinico-epidemiological profile and adherence to anti tubercular treatment among tuberculosis patients.
Methods: It was a cross sectional study done among 462 tuberculosis patients visiting G. G. Rathi Tuberculosis hospital during period January 2020 to April 2020.
Results: Out of total 462 study subjects 268 (58%) were male and 194 (42%) were female. Most of i.e. 143 (30.9%) were from age group 41-50 years. majority i.e. 148 (32.0%) were educated up to secondary school. As per Morisky medication adherence scale-4, majority 325 (70.4%) study subjects were having high adherence.
Conclusions: About 8% of the patients were having low adherent. Age and education of study subject was found to be significantly associated with adherence.
Metrics
References
Kumar SV, Deka MK, Bagga M, Kala MS, Gauthaman K. A systematic review of different type of tuberculosis. Eur Rev Med Pharmacol Sci. 2010;14(10):831-43.
Wani RL. Clinical manifestations of pulmonary and extra-pulmonary tuberculosis. South Sudan Med J. 2013;6(3):52-6.
Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med. 2002;347(18):1420-5.
Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4:68.
Morgado A, Kohnenkampf R, Navarrete P, García P, Balcells ME. Clinical and epidemiological profile of tuberculosis in a university hospital in Santiago, Chile. Rev Med Chil. 2012;140(7):853-8.
WHO. Research for Action: Understanding and Controlling TB in India. New Delhi: WHO. Available at: www.who.int/mediacentre/factsheets/
fs104/en. Accessed on 15 December 2019.
Unnikrishnan B, Holla R, Darshan BB, Arjun BY, Thapar R, Mithra P, et al. Clinico epidemiological profile of HIV-TB co-infected patients in Coastal South India. Manipal J Nurs Health Sci. 2015;1(1):9-13.
Jaiswal RK, Srivastav S, Mahajan H. Socio demographic profile of PTB-HIV coinfected patients in Bundelkhand region, Uttar-Pradesh, Natl J Med Res. 2012;2(2):149-51.
Kar H, Pai C, Sharma R, Bhattacharjee M, Pachpute S. A profile of tuberculosis cases among HIV positive patients in Navi Mumbai. Int J Life Sci Pharm Res. 2015;5(3).
Kumar P. Clinical profile of tuberculosis in patients with HIV infection/AIDS. Indian J Chest Dis Allied Sci. 2002;44:159-63.
Swarooprani NB, Wadekar MD, Rajakumar S. Impact of CD4 Count on sputum smear for AFB in HIV-TB co infection. Indian J Microbiol Res. 2016;3(2):126-9. 64.
Taraphdar P. socioeconomic consequences of HIV/ AIDS in family system. Nigerian medical journal, 52(4), 2011, 250-253.
Vasava R et al. Tuberculosis in HIV coinfected patients- Study of clinical profile and laboratory datas with special consideration to CD4 counts at Tertiary care hospital, International journal of scientific research January 2015; 4(1):2277– 8179.
Patel AK, Thakrar SJ, Ghanchi FD. Clinical and laboratory profile of patients with HIV PTB coinfection, a case resies of 50 patients. Lung India. 2011;28:93.
Bagchi S, Ambe G, Sathiakumar N. Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prev Med. 2010;1(4):223-32.
Kulkarni PY, Akarte SV, Mankeshwar RM, Bhawalkar JS, Banerjee A, Kulkarni AD. Non- adherence of new pulmonary tuberculosis patients to anti. Tuberculosis treatment. Ann Med Health Sci Res. 2013;3(1):67-74.